Europe Clinical Nutrition Market - Size, Share, and Forecast (2025-2033)

Europe Clinical Nutrition Market – Industry Trends & Outlook

The Europe clinical nutrition market was valued at US$ 19.82 Billion in 2023. The market size reached US$  21.01 Billion in 2024 and is expected to reach US$ 36.63 Billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033.

The Europe clinical nutrition market refers to the sector focused on providing specialized nutritional products and therapies designed to support the dietary needs of individuals with medical conditions such as malnutrition, metabolic disorders, gastrointestinal diseases, cancer, and neurological disorders. Clinical nutrition involves the use of tailored supplements and dietary interventions to prevent, diagnose, and manage nutritional alterations in patients, thereby improving their overall health, recovery outcomes, and quality of life.

Key drivers of the Europe clinical nutrition market include the rising prevalence of chronic diseases and metabolic disorders like diabetes and obesity, the rapidly growing geriatric population prone to nutrition-related complications, and increasing awareness among healthcare professionals and the public about the importance of nutrition in disease management and recovery. Additionally, government initiatives promoting hospital-based nutrition programs and the demand for personalized nutrition solutions are fueling market growth.

Major trends shaping the market include the shift towards personalized and evidence-based nutritional interventions, the adoption of enteral and Pediatric Nutrition products in hospitals, and the emergence of organic and plant-based clinical nutrition solutions. 

The Europe clinical nutrition market presents significant opportunities for growth, particularly in developing tailored nutrition solutions for the expanding elderly population and for patients with chronic illnesses. Companies can capitalize on the increasing demand for home-based and specialized clinical nutrition products, as well as the growing acceptance of medical nutrition in preventive healthcare. Expansion into underserved regions, product innovation, and leveraging digital distribution channels further enhance the market’s potential.

Europe Clinical Nutrition Market – Executive Summary 

Europe Clinical Nutrition Market Dynamics: Drivers

Rise in the prevalence of metabolic disorders

The clinical nutrition market is experiencing growth due to factors such as rising metabolic disorders, high healthcare spending, and the rise of the middle class in emerging economies, indicating a growing market. The rise in the prevalence of metabolic diseases, such as obesity, hypertension, insulin resistance, and hyperlipidemia, is a significant public health issue worldwide.

Moreover, the rise in the prevalence of diabetes in Romania plays an important role in Europe clinical nutrition market to grow during the forecast period. Clinical nutrition plays a crucial role in the management and prevention of diabetes, particularly type 2 diabetes (T2D), which is a rapidly growing epidemic with increased mortality rates and health care costs. Nutrients, such as carbohydrates, fat, protein, mineral substances, and vitamins, are central to metabolic homeostasis and glucose metabolism regulation.

People with Diabetes, in 1,000s of age (20-79) in Romania

For instance, according to the International Diabetes Federation, in Romania between the ages of 20-79 years in 2021, 1,199 people suffered from diabetes, and it is expected to grow to around 1,203 by 2030 and decrease in 2045. Hence, the rise in the prevalence of diabetes indeed the need for clinical nutrition is required and overall helps the market to grow during the forecast period.

Hence, the rise in the number of metabolic disorders and other chronic diseases will increase the demand for clinical nutrition directly, which will help the market to grow during the forecast period.

Increasing government initiatives

Increasing government initiatives are a major driver for the Europe clinical nutrition market, as many European governments are actively implementing policies and programs to improve public health through better nutrition. For example, countries like Germany have launched comprehensive strategies such as "Good Food for Germany," which aims to enhance the population's overall health and nutrition by combating malnutrition and promoting healthy dietary practices. 

In the UK, the National Health Service (NHS) sponsors and standardizes clinical nutrition programs, making nutrition therapy a fundamental part of disease management in hospitals and care settings. Additionally, governments across Europe are supporting hospital-based nutrition programs, home-based enteral feeding solutions, and public awareness campaigns like Nutrition and Hydration Week and Malnutrition Awareness Week to educate healthcare professionals and the public about the importance of clinical nutrition. 

For instance, in February 2025, the European Parliament recently hosted a high-level roundtable titled “Advancing Optimal Nutritional Care: Addressing Disease-Related Malnutrition in Europe,” organized by the Medical Nutrition International Industry (MNI) and chaired by MEP Vytenis Andriukaitis (S&D, Lithuania), with strong support from MEP Tomislav Sokol (EPP, Croatia).  These initiatives not only increase awareness and accessibility but also encourage innovation, research, and the adoption of clinical nutrition products, significantly contributing to the growth and development of the market across the region.

Europe Clinical Nutrition Market Dynamics: Restraints

Lack of awareness of clinical nutrition

The demand for clinical nutrition is increasing, but there is a lack of awareness about healthcare and diet in both developed and developing countries. This lack of understanding leads to deficiencies and disorders due to a lack of proper knowledge of vitamins and nutrition, and incorrect information.

Education and direct support for health and hygiene are not sufficient. Despite campaigns promoting awareness about clinical nutrition benefits for different diseases, there is still a lack of understanding about clinical nutrition for various illnesses, which is expected to hamper the market. 

However, lack of awareness, especially in emerging countries, and stringent government regulations are a few of the restraints that may result in lower adoption of alternate means of nutrition. The clinical nutrition market growth can be affected in the least developed regions of the world with comparatively lower standards of living, attributed to the refusal of rationalized means to consume nutrition and, lack of acceptance of newer approaches. These factors will hamper the growth of the market in the forecast period.

Rise in the challenges in low-resource settings.

The rise in challenges in low-resource settings can act as a restraint on the European clinical nutrition market by indirectly impacting supply chains, resource availability, and global priorities. Many clinical nutrition ingredients are sourced from or processed in these regions, and disruptions due to poor infrastructure, political instability, or health crises can lead to supply shortages and increased costs for European manufacturers. 

Additionally, growing nutrition-related health issues in low-income countries drive up global demand, creating competition for limited resources and potentially inflating prices.

Europe Clinical Nutrition Market Dynamics: Opportunities

Increasing focus of consumers on health and wellness

The increasing focus of consumers on health and wellness is driving the adoption of organic and sustainable ingredients in clinical nutrition. Patients and health practitioners are showing heightened interest in natural nutritional solutions, clean-label products, and those produced in an environmentally responsible way.

 This presents a major opportunity for clinical nutrition product manufacturers to develop formulations with organic and sustainably-sourced ingredients. Clinical nutrition products with organic and sustainable ingredients appeal to consumers' evolving values of environmental protection and personal health. As people become more informed about the detrimental health impacts of pesticides, preservatives, and artificial ingredients, they are increasingly trusting of nutritional therapies derived from organic agriculture.

For more details on this report, Request for Sample

Europe Clinical Nutrition Market - Segment Analysis

The Europe clinical nutrition market is segmented based on product type, age group, route of administration, application, and Distribution Channel.

Product Type:

The Adult Nutrition product type segment in the Europe clinical nutrition market in 2024 was valued at US$ 9.16 Billion 2024 

Adult Nutrition is an essential aspect of healthcare for individuals with a functioning digestive system who are unable to eat or drink. Nestlé Health Science, a global leader in the field, offers a wide range of enteral feeding products and solutions designed to support various life stages, from pediatrics to healthy aging. If the gut is working normally to absorb food and nutrients, then Adult Nutrition is the preferred way of delivering nutritional support. In some patients, Adult Nutrition may have to be delivered into the gut through a tube, but in others, it may be possible for them to take this by mouth. 

The Adult Nutrition segment is expected to grow during the forecast period by various factors like, rise in the prevalence of malnutrition in the country and region novel product launches in the region, advancements and others help the segment to grow during the forecast period.

For instance, according to the Global Nutrition Report, Romania is on track to meet one target for maternal, infant, and young child nutrition (MIYCN), but no progress has been made in reducing anaemia among reproductive-age women, with 22.7% affected. Romania has made some progress in achieving stunting targets, but 12.8% of children under 5 still face issues, higher than the average for Europe.

As the number of children suffering from malnutrition in Romania is increasing, the need for Adult Nutrition plays a vital role in managing malnutrition in critically ill patients. Early identification and intervention, combined with appropriate formula selection and feeding protocols, can significantly improve clinical outcomes and reduce complications. Hence, the Adult Nutrition segment is expected to grow during the forecast period.

Moreover, in March 2024, ESPEN launched an updated guideline on nutrition in IBD. Nutritional status should be checked before surgery and treated accordingly with diet in patients with malnutrition. Normal food intake, oral nutritional supplements, or Adult Nutrition are affordable for most patients with IBD after surgery.

Europe Clinical Nutrition Market – Competitive Landscape

The major players in the Europe clinical nutrition market include Abbott Laboratories (Abbott Nutrition), Nestle Health Science, Baxter International Inc., B. Braun Melsungen AG, Danone (Nutricia), BASF SE, Perrigo Company PLC, Royal DSM, AYMES International Ltd, and Nualtra, among others.

Europe Clinical Nutrition Market – Key Developments

• In February 2025, SFI Health EMEA, the regional division of global natural healthcare leader SFI Health, announced the launch of Equazen food supplements in Portugal. Equazen is a science-based brand specifically developed to support cognitive needs such as learning, concentration, and healthy brain development across all life stages.

• In August 2024, Abbott announced it is expanding its Pure Bliss by Similac line of infant formulas. This expansion means parents now have more choices when it comes to feeding their babies, with products that cater to different preferences and needs.

• In March 2024, Sirio Pharma, a leading global nutraceutical contract development and manufacturing organization (CDMO), is launching a comprehensive women’s health platform at Vitafoods Europe. This platform features a portfolio of 25 ready-to-launch formulations that are specifically personalized to women’s health needs across all life stages from puberty through post-menopause.

Europe Clinical Nutrition Market – Scope

DMI Insights:

According to DMI analysis, the Europe clinical nutrition market was valued at US$ 19.82 Billion in 2023. The market size reached US$ 21.01 Billion in 2024 and is expected to reach US$ 36.63 Billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033.

The Europe clinical nutrition market is primarily driven by the rising prevalence of chronic diseases and metabolic disorders, such as diabetes, cancer, and cardiovascular conditions, which require specialized nutritional support for effective management. The rapidly aging population in Europe is another major driver, as older adults are more susceptible to malnutrition and related health complications.

 Additionally, increased awareness among healthcare professionals and patients about the benefits of clinical nutrition, along with ongoing government initiatives to promote nutrition therapy in hospitals and home care settings, are significantly boosting market growth. The growing number of product launches and the expansion of e-commerce platforms for supplement distribution further contribute to the market’s growth.

Key trends in the European clinical nutrition market include a shift toward personalized and evidence-based nutrition interventions, with a focus on tailored solutions for specific patient groups such as the elderly and those with metabolic disorders. There is growing adoption of enteral and Pediatric Nutrition products in hospitals, as well as increased demand for organic and plant-based clinical nutrition offerings. 

Market growth will be fueled by continued advancements in clinical nutrition research, expanding government support for nutritional interventions, and the integration of digital health technologies. Opportunities abound for companies to develop innovative, personalized nutrition products and expand into underserved regions. As healthcare systems increasingly recognize the critical role of nutrition in disease management and recovery, clinical nutrition is set to become an even more integral part of patient care across Europe.

The Europe clinical nutrition market report delivers a detailed analysis with 45 key tables, more than 37 visually impactful figures, and 156 pages of expert insights, providing a complete view of the market landscape.